Sfoglia per Autore
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation
2024 Utkina-Sosunova, I; Chiorazzi, A; de Planell-Saguer, M; Li, H; Meregalli, C; Pozzi, E; Carozzi, V; Canta, A; Monza, L; Alberti, P; Fumagalli, G; Karan, C; Moayedi, Y; Przedborski, S; Cavaletti, G; Lotti, F
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain
2022 Bloomingdale, P; Meregalli, C; Pollard, K; Canta, A; Chiorazzi, A; Fumagalli, G; Monza, L; Pozzi, E; Alberti, P; Ballarini, E; Oggioni, N; Carlson, L; Liu, W; Ghandili, M; Ignatowski, T; Lee, K; Moore, M; Cavaletti, G; Mager, D
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118)
2021 Pero, M; Meregalli, C; Qu, X; Ji-Eun Shin, G; Kumar, A; Shorey, M; Rolls, M; Tanji, K; Brannagan, T; Alberti, P; Fumagalli, G; Monza, L; Grueber, W; Cavaletti, G; Bartolini, F
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity.
2021 Alberti, P; Malacrida, A; Ballarini, E; Nicolini, G; Semperboni, S; Canta, A; Fumagalli, G; Pozzi, E; Scuteri, A; Cavaletti, G
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY
2021 Quartu, M; Serra, M; Fumagalli, G; Oggioni, N; Boi, M; Marmiroli, P; Cavaletti, G; Meregalli, C
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY
2021 Fumagalli, G; Ballarini, E; Chiorazzi, A; Monza, L; Alberti, P; Oggioni, N; Marmiroli, P; Cavaletti, G; Meregalli, C
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research
2021 Monza, L; Fumagalli, G; Chiorazzi, A; Alberti, P
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function
2021 Monza, L; Fumagalli, G; Chiorazzi, A; Alberti, P
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model.
2021 Alberti, P; Bontempi, P; Gerevini, S; Napolitani, A; Daducci, A; Schiavi, S; Canta, A; Chiorazzi, A; Fumagalli, G; Monza, L; Pozzi, E; Marzola, P; Cavaletti, G; Stefano, T
Assessment of Neurofilament Light Protein as a Serum Biomarker in Rodent Models of Toxic-Induced Peripheral Neuropathy
2021 Fumagalli, G; Cavaletti, G; Zetterberg, H; Meregalli, C
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy
2021 Fumagalli, G; Monza, L; Cavaletti, G; Rigolio, R; Meregalli, C
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy
2021 Pero, M; Meregalli, C; Qu, X; Shin, G; Kumar, A; Shorey, M; Rolls, M; Tanji, K; Brannagan, T; Alberti, P; Fumagalli, G; Monza, L; Grueber, W; Cavaletti, G; Bartolini, F
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity
2021 Meregalli, C; Monza, L; Chiorazzi, A; Scali, C; Guarnieri, C; Fumagalli, G; Alberti, P; Pozzi, E; Canta, A; Ballarini, E; Rodriguez-Menendez, V; Oggioni, N; Cavaletti, G; Marmiroli, P
Genetic factors influencing the development of vincristine-induced neurotoxicity
2021 Pozzi, E; Fumagalli, G; Chiorazzi, A; Canta, A; Cavaletti, G
The role of Neurofilament Light Chain as a serum biomarker in chemotherapy-induced peripheral neurotoxicity rat models
2020 Fumagalli, G
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN)
2020 Alberti, P; Ballarini, E; Canta, A; Chiorazzi, A; Fumagalli, G; Malacrida, A; Meregalli, C; Pozzi, E; Marmiroli, P; Cavaletti, G
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery.
2020 Alberti, P; Ballarini, E; Canta, A; Chiorazzi, A; Fumagalli, G; Malacrida, A; Meregalli, C; Monza, L; Pozzi, E; Marmiroli, P; Cavaletti, G
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification
2020 Dionisi, M; Ruffinatti, F; Riva, B; Lim, D; Canta, A; Meregalli, C; Fumagalli, G; Monza, L; Ferrer-Montiel, A; Fernandez-Carvajal, A; Cavaletti, G; Genazzani, A; Distasi, C
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back.
2020 Alberti, P; Ballarini, E; Canta, A; Chiorazzi, A; Fumagalli, G; Malacrida, A; Monza, L; Pozzi, E; Meregalli, C; Marmiroli, P; Cavaletti, G
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594
2020 Canta, A; Chiorazzi, A; Pozzi, E; Fumagalli, G; Monza, L; Meregalli, C; Carozzi, V; Rodriguez-Menendez, V; Oggioni, N; Nasstrom, J; Marmiroli, P; Cavaletti, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile